معرفی
Simon Ekman is a Professor of Oncology at Karolinska Institutet and Senior Physician at Karolinska University Hospital. His research focuses on precision cancer medicine in lung cancer, particularly mechanisms of therapy resistance (tyrosine kinase inhibitors, immunotherapy) and brain metastasis. He leads translational programs integrating molecular profiling of tumors and liquid biopsies (plasma, CSF, pleural effusions) with PET imaging and clinical trials.
- Appointments: Professor (Karolinska, 2023), Chief Physician (Karolinska University Hospital, 2015)
- Education: Medical degree and PhD (Uppsala University, 2000), Postdoc (Rudbeck Laboratory, 2002-2005), Visiting Research Fellow (University of Colorado, 2011-2012)
His work includes 15 recent articles on topics like exosome-based diagnostics, miRNA-driven resistance, and brain metastasis imaging. Collaborations span institutions including University of Colorado, Oslo University, and University of Manchester. He has secured major grants from the Sjöberg Foundation and Erling Persson Foundation.
Scientific awards and funding include
- SEK 18 million from Sjöberg Foundation (2021)
- Erling Persson Foundation support for nanotechnology diagnostics
- Swedish Cancer Society and Research Council grants
Simon Ekman's clinical expertise includes NSCLC/SCLC treatment, stereotactic radiotherapy, and brain metastasis management. His group involves principal investigators like Per Hydbring and Kristina Viktorsson, with PhD students and postdocs analyzing tumor biology and therapeutic strategies.
